Solante, RontgeneRontgeneSolanteAlvarez-Moreno, CarlosCarlosAlvarez-MorenoBurhan, ErlinaErlinaBurhanChariyalertsak, SuwatSuwatChariyalertsakChiu, Nan-ChangNan-ChangChiuChuenkitmongkol, SunateSunateChuenkitmongkolDung, D VD VDungHwang, Kao-PinKao-PinHwangOrtiz Ibarra, JavierJavierOrtiz IbarraKiertiburanakul, SasisopinSasisopinKiertiburanakulKulkarni, Prasad SPrasad SKulkarniLee, ChristopherChristopherLeePING-ING LEELobo, Rommel CrisenioRommel CrisenioLoboMacias, AlejandroAlejandroMaciasNghia, Cao HuuCao HuuNghiaOng-Lim, Anna LisaAnna LisaOng-LimRodriguez-Morales, Alfonso JAlfonso JRodriguez-MoralesRichtmann, RosanaRosanaRichtmannSafadi, Marco Aurélio PalazziMarco Aurélio PalazziSafadiSatari, Hindra IrawanHindra IrawanSatariThwaites, GuyGuyThwaites2023-01-182023-01-182022-11-1114760584https://scholars.lib.ntu.edu.tw/handle/123456789/627424COVID-19 vaccines have been highly effective in reducing morbidity and mortality during the pandemic. However, the emergence of the Omicron variant and subvariants as the globally dominant strains have raised doubts about the effectiveness of currently available vaccines and prompted debate about potential future vaccination strategies.enAZD1222; COVID-19; CoronaVac; booster; mRNA; omicron; severe; vaccine effectiveness; waning immunityjournal article10.1080/14760584.2023.2143347363309712-s2.0-85142148414https://api.elsevier.com/content/abstract/scopus_id/85142148414